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ABSTRACT 
Background and Objectives：Allergic rhinitis (AR) and rhinitis medicamentosa (RM) have different mucosal color and 
pathophysiology. To investigate whether the mucosal color and nasal blood flow are different between the diseases in spite of 
same symptoms, we designed this study. Materials and Methods：20 patients with allergic rhinitis and 21 patients with 
rhinitis medicamentosa were compared with 20 normal volunteers  using mucosal color grading and Laser Doppler flowmetry. 
The Laser Doppler flowmetry was performed with a Periflux 4001 (Perimed, Jrtlla, Sweden) and perfusion unit  (PU), velocity 
unit  (VU), and concentration Unit (CU) were measured. The Laser Doppler flowmetry data in AR and RM  were compared 
with those of the normal subjects, and between AR and RM. Results：The perfusion score of AR and RM were lower than 
the control (p< 0.05) and it was statistically significant that the mucosal color of AR were pale and of RM were reddish, 
comparing to the control group (p< 0.05). Conclusion：The nasal blood flow was decreased with AR and RM compared to 
control but the mucosal color of AR and RM were different because of the difference of pathophysiology of diseases. When 
diagnosing RM, observation of mucosal color and measurement of nasal blood flow will be helpful besides the history of 
long-term use of nasal decongestant. 
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INTRODUCTION  
 
The interrelationship between mucosal findings and 
mucosal perfusion in inflammatory nasal diseases have 
been very helpful in the clinical diagnosis and treatm-
ent of this disorder. Allergic rhinitis is an inflammatory 
disease of the nasal mucosa that has main symptoms 
such as itching, sneezing, watery rhinorrhea and nasal 
obstruction. It shows pale and bluish mucosal findings. 
Within minutes of exposure to an allergen, mediators 
such as  histamine, tryptase, prostaglandin D2, leuco-
triene C4, kinin and so forth are secreted and an early 
response occurs which is followed by findings such as 
vasodilation, increase of vascular permeability and 
mucosal edema. Thereafter 3- 11 hours, eosinophil, 
neutrophil and histamine, TAME esterase, kinin and so 
forth increase followed by a late response that causes 
nasal obstruction, sneezing and rhinorrhea.1)2) 
Differently, Fox3) first stated the possibility of rhi-
nitis medicamentosa in 1931 and in 1946 Lake4) for 
the first time named it rhinitis medicamentosa. This is 
a disorder where nasal obstruction is complained after 
longterm use of sympathomimetics. It shows reddish 
mucosal findings that cause rebound vasodilatation 
and mucosal congestion. The clinical expressions may 
vary by the type of medication or the patient.5) About 
the pathophysiology of this disorder, Baldwin6) et al., 
reported that the stimulating effec t of the β-receptors 
of symapthomimetics exceeds the stimulating effect of 
α-receptors which causes noradrenaline depletion in 
the nerve endings that cause tolerance. However, other 
possibilities such as rebound vasodilation caused by 
ischemia and edema, 7) over-stimulaiton of α-2 recep-
tors8) and over-acceleration of parasympathetic nerves 9) 
are mentioned as well. 
1Department of Otorhinolaryngology, 2the BK21 Project for Me-
dical Science, Yonsei University College of Medicine, Seoul, 
Korea 
Address correspondences and reprint requests to Jong Bum Yoo,
M.D., Department of Otorhinolaryngology, Yonsei University 
College of Medicine, 134 Shinchon-dong, Seodaemun-gu, Seoul
120-752, Korea 
Tel：82-2-361-8489, Fax：82-2-393-0580 
E-mail：shin93@yumc.yonsei.ac.kr  
Accepted for publication on October 5, 2002 
 
 
 
 
 
Lee et al：LDF for Allergic Rhinitis  and Rhinitis  Medicamentosa / 31 
 
Until now, methods such as Hydrogen clearance 
method10) or Xenon washout method11) have been used 
to measure nasal mucosal perfusion, however, they are 
all invasive and have a limit in measuring physiologic 
nasal mucosal perfusion. Thereafter, Stern12) first intro-
duced a noninvasive method where the dopper theory 
is used to measure the micro-circulating perfusion. 
Olsson13) et al., introduced Laser Doppler blood fl-
owmetry for mucosal perfusion measurement. Laser 
Doppler blood flowmetry has excellent reproducibility 
and is noninvasive and because it shows mucosal 
perfusion precisely, it has been actively used in the 
research of the pathophysiology of the nasal mucosa. 14) 
It has also been valuably used in the evaluation of the 
nasal mucosa state in our country as well.15) 
Therefore in this study we wish to compare the ab-
normal mucosal color and mucosal perfusion findings 
in allergic rhinitis and rhinitis medicamentosa patients 
using laser Doppler flowmetry and to assist in clinically 
adopting it.  
 
MATERIAL AND METHOD  
 
Experimental Group 
 
This study was based on 20 patients that visited our 
OPD from November through December 2001 that 
were diagnosed with perennial allergic rhinitis through 
an intradermal skin test and whose chief complaint 
was nasal obstruction. The age distribution ranged 
from 17 through 68 years old (average age 41 years 
old). The sex distribution was 6 male and 14 female. 
Also, based on 21 rhinitis medicamentosa patients that 
visited our OPD from January 2000 through June 2002 
that had accompanying nasal septal deviation and 
nasal obstruction caused by topical nasal decongestant 
used for over 6 months. The age distribution ranged 
from 19 through 57 years old (average age 37 years 
old) and the sex distribution was 17 male and 4 female. 
The control group consisted of 20 healthy people in a 
similar age group with the experimental group that had 
normal findings on anterior nasal inspection and had 
no past history of allergic rhinitis or rhinitis medicame-
ntosa. The sex distribution was 10 male and 10 female 
and the age distribution ranged from 20 through 55 
years old (average age 35 years old)(Table 1). 
 
Experimental method 
 
The mucosal finding was measured through obser -
vation of the anterior portion of the inferior turbinate 
with no specific treatment before using the laser Do-
ppler flowmetry. Severe pale was regarded as grade 0, 
pale as grade 1, severely hyperemic as grade 4, 
hyperemic as grade 3 and normal as grade 2. One 
tester carried out scoring by comparing a picture of a 
patient showing distinct pale or hyperemic mucosal 
findings. To inquire measurement of nasal perfusion 
using laser Doppler flowmetry, patients rested 1- 2 
hours before testing. Foreign bodies or crust, mucoid 
secretion and so forth of the nasal cavity were all 
removed. To measure nasal mucosal perfusion, a laser 
dopper flowmetry (Periflux 4001 laser doppler perfu-
sion meter, Perimed, Jrtlla, Sweden) that uses 780 nm 
of laser beam was applied.16) 
  
Analysis of results 
 
The results were analyzed by an analytical program 
known as the Perisoft program (Perimed, Jrtlla, Sw-
eden) and mucosal perfusion, velocity and RBC con-
centration was measured. Measuring units used in this 
study were perfusion unit (PU), concentration unit 
(CU) and velocity unit (VU) each voluntarily named 
by perisoft program. Throughout the entire research 
period a well experienced tester of the nose function 
laboratory carried out all tests.  
 
Statistical method 
 
As a statistical method, the ANOVA test was used to 
compare the perfusion and RBC concentration and 
velocity between the allergic rhinitis and rhinitis medi-
camentos group with the control group. The student T-
test was applied for mucosal color comparison (p<0.05). 
 
Table 1. Age and sex distribution of allergic rhinitis, rhinitis me-
dicamentosa and control group 
Sex  
Group Number 
Male Female 
Age mean 
(range) 
Allergic rhinitis 20 06 14 41 (17-68) 
Rhinitis medicamentosa 21 17 04 37 (19-57) 
Control 20 10 10 35 (20-55) 
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RESULT  
 
Comparison of mucosal color between the alle-
rgic rhinitis and rhinitis medicamentosa group 
with the control group. 
The mucosal color in allergic rhinitis was 0.55±
0.51 (mean±SD), 3.35±0.75 in rhinitis medicamen-
tosa and 2.20±0.41 in the control group. Based on a 
multiple analysis using the ANOVA test all three group 
showed a significant difference among one another 
(p<0.05). On the other hand, an analysis based the 
interrelationship between the mucosal color and per-
fusion using the T-test shows that when the mucosal 
color is 2 the perfusion is 157.43±49.10 PU, when 3, 
107.63±21.47 PU and when 4, 105.91±24.55 PU. 
The perfusion was significantly higher when the mu-
cosal color was 2, compared to when it was 3 or 4 (p< 
0.05)(Fig. 1). 
 
Comparison of perfusion between the allergic 
rhinitis and rhinitis medicamentosa group with 
the control group  
The perfusion was 117.34±10.85 PU (mean±SD) 
in allergic rhinitis, 114.23±32.16 PU in rhinitis medi-
camentosa and 154.12±21.88 PU in the control group. 
Based on a multiple analysis using the ANOVA test, 
perfusion in allergic rhinitis and rhinitis medicamen-
tosa was significantly lower (p<0.05) compared to the 
control group, however, there was no statistical meaning 
between the allergic rhinitis and rhinitis medicamentosa 
group. Velocity and RBC concentration compared in 
the allergic rhinitis and rhinitis medicamentosa with 
the control group showed that the velocity was 158.33
±80.27 VU (mean±SD) and the RBC concentration 
was 83.77±23.49 CU in allergic rhinitis, and 240.79
±87.98 VU and 55.65±23.11 CU, relatively, in rhi-
nitis medicamentosa. Based on a comparison multiple 
analysis using the ANOVA test of the control group 
where the velocity was 281.68±77.74 VU and RBC 
concentration was 58.77±17.15 CU, the velocity in 
allergic rhinitis compared to rhinitis medicamentosa 
and the control group, was significantly lower (p<0.05), 
however, there was no statistical meaning between 
rhinitis mediccamentosa and the control group. The 
RBC concentration was significantly higher (p<0.05) 
in allergic rhinitis compared to rhinitis medicamentosa 
and the control group, however, there was no statistical 
meaning between rhinitis medicamentosa and the con-
trol group (Table 2). 
 
DISCUSSION  
 
History and symptoms, nasal cavity examination all 
play an important role in the diagnosis and treatment 
of patients suspected of any rhinologic disorder. An 
attempt to clinically adapt an objective observation of 
mucosal congestion and perfusion has been executed. 
In such researches, rhinomanometry was mostly used 
for mucosal congestion evaluation, however, due its 
limitations as an indirect method it has been reported, 
on the other hand, that using laser Dopper flowmetry 
together has been more useful in measuring mucosal 
congestion and perfusion.14) 
Laser Doppler flowmetry operates based on the 
theory of irradiating laser beam to the tissue through 
laser fiber where a portion is reflected back out from 
moving materials (usually RBC) in the tissue which 
causes a frequency change according to the Doppler 
effect. The reflected laser beam is absorbed by a 
photodetector where the frequency change is recorded 
and by a signal processor, the power is output as an 
electrical sign.13) Perfusion, RBC concentration and 
velocity are measured through this process and the 
tissue perfusion is proportionate to RBC concentration 
and velocity.  
Table 2. Laser Doppler flowmetry score of allergic rhinitis. rhini-
tis medicamentosa and control 
 Perfusion Concentration Velocity 
Allergic rhinitis 117.84* 83.78*† 158.33*†
Rhinitis medicamentosa 114.23* 55.65† 240.79† 
Control 154.12 58.77 281.68 
*：Statistically different from control, †：Statistically different 
between allergic rhinitis and rhinitis medicamentosa 
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Fig. 1. Mucosal color of allergic rhinitis (AR), rhinitis medicame-
ntosa (RM) and control (C). 
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Based on a comparison between mucosal color and 
perfusion between rhinitis medicamentosa and allergic 
rhinitis with the control group, decrease of perfusion 
and hyperemic mucosa findings in rhinitis medica-
mentosa showed a significant difference compared to 
the control group, however, RBC concentration and 
velocity did not show any statistical difference com-
pared to the control group and is, therefore, considered 
that despite submucosal vasodilation, perfusion was 
not increased. Hyperemic nasal mucosa finding is 
considered clinically meaningful, however, because hy-
peremic findings of the nasal mucosa occurred despite 
no increase of RBC concentration in the rhinitis medi-
camentosa, the relationship between RBC concentration 
and mucosal color has not been established in this 
study. It is estimated that there probably are other 
factors that affect mucosal color other than RBC con-
centration, which will require further research. Also, 
decrease of perfusion and pale mucosal color in allergic 
rhinitis showed a significant difference compared to 
the control group. RBC concentration was high and 
velocity was low compared to the control group. Such 
decrease of perfusion is considered to be caused by 
RBC concentration increase due to mucosal edema and 
decrease of velocity. It is considered that the mucosal 
vasoconstriction17) of histamine is also involved in pale 
mucosal color, along with mucosal edema. When 
compared, mucosal color is pale in allergic rhinitis and 
hyperemic in rhinitis medicamentosa and perfusion 
was significantly low in both groups compared to the 
control group. As such, there was a difference in 
mucosal color even though perfusion has decreased 
identically in both groups and this is regarded to have 
originated from the pathophysiological difference of 
mucosal edema and vasoconstriction in allergic rhinitis 
and rebound vasodilation in rhinitis medicamentosa. 
Along with this, among mucosal color and perfusion, 
perfusion showed a statistically significant increase 
compared to hyperemic or pale findings of normal 
mucosa. Therefore it is considered that continuous 
laser Doppler flowmetry measurement could be useful 
in the evaluation of the patient’s improvement during 
treatment. However, because the diagnostic standard of 
rhinitis medicamentosa is still obscure, we depended 
mostly on past history and physical examination. It is 
also regarded that there were probably patients that 
have already been somewhat treated at a different hos-
pital before coming to our hospital and the possibility 
that an underlying disease may have affected the results 
cannot be excluded. Also, it is considered that it would 
have been more clinically useful if research on the 
interrelationship between clinical symptoms and ex-
amination findings and laser Doppler flowmetry have 
been executed. 
 
CONCLUSION   
 
In this study, based on allergic rhinitis and rhinitis 
medicamentosa patients that admitted with nasal ob-
struction, there was a difference in mucosal color in 
both cases while nasal perfusion, on the other hand, 
decreased identically in both cases. To take notice of 
this fact, we studied the clinical use of laser Dopper 
flowmetry and the difference of symptom expression. 
As a result, it is considered that past history use of 
nasal decongestant along with hyperemic mucosal co-
lor and decrease of nasal perfusion will be very useful 
in the future diagnosis of rhinitis medicamentosa and 
can also, possibly be useful in the judgment of treat-
ment process. 
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